This study was aimed to explore the effects of QRQZ on improving gut mucosal permeability by regulating gut microbiota, and its mechanism in the inhibition of the TLR4/NF-κB signaling pathway activation to alleviate NASH. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.